Request Demo
Last update 20 May 2025
Emicizumab biosimilar(Wuhan YZY Biopharma)
Last update 20 May 2025
Overview
Basic Info
Drug Type Bispecific antibody, Biosimilar |
Synonyms Emicizumab Biosimilar (Wuhan YZY Biopharma Co., Ltd.), 艾美赛珠单抗生物类似药（武汉友芝友生物制药股份有限公司）, Y225 |
Target |
Action inhibitors |
Mechanism F10 inhibitors(Coagulation factor X inhibitors), factor IXa inhibitors(Factor IXa inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Structure/Sequence
Sequence Code 5386H
The sequence is quoted from: *****
Sequence Code 5425H
The sequence is quoted from: *****
Sequence Code 5467L
The sequence is quoted from: *****
Related
1
Clinical Trials associated with Emicizumab biosimilar(Wuhan YZY Biopharma)CTIS2022-502060-21-00
Nuwiq for Perioperative management Of patients With haemophilia A on Emicizumab Regular prophylaxis study (NuPOWER) - GENA-22
100 Clinical Results associated with Emicizumab biosimilar(Wuhan YZY Biopharma)
Login to view more data
100 Translational Medicine associated with Emicizumab biosimilar(Wuhan YZY Biopharma)
Login to view more data
100 Patents (Medical) associated with Emicizumab biosimilar(Wuhan YZY Biopharma)
Login to view more data
100 Deals associated with Emicizumab biosimilar(Wuhan YZY Biopharma)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hemophilia | Preclinical | China | 19 May 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free